Updated Jul 16, 2026
Ali Asif has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $7.32M.

Asif Ali serves as Chief Financial Officer of Protagonist Therapeutics, Inc. (PTGX). The SEC filing with CIK 0001921163 dated 2026-01-21 lists him as CFO and shows no reported purchases or sales in that filing, indicating his role as the company's finance leader during the period covered by the filing. Protagonist is a clinical-stage biopharmaceutical company developing constrained peptide-based drug candidates, including Rusfertide (PTG-300) and JNJ-2113.
| Role | Chief Financial Officer |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-21 | PTGX | Protagonist Therapeutics, Inc | S — Open-market sale | 1.8K | $105.47 | $185K |
| 2026-03-27 | PTGX | Protagonist Therapeutics, Inc | S — Open-market sale | 24.8K | $104.24 | $2.58M |
| 2026-03-27 | PTGX | Protagonist Therapeutics, Inc | M — Option exercise | 5.3K | $12.17 | $64K |
| 2026-03-27 | PTGX | Protagonist Therapeutics, Inc | M — Option exercise | 19.5K | $19.19 | $374K |
| 2026-01-28 | PTGX | Protagonist Therapeutics, Inc | S — Open-market sale | 18.2K | $83.14 | $1.51M |
| 2026-01-28 | PTGX | Protagonist Therapeutics, Inc | S — Open-market sale | 28.0K | $83.13 | $2.33M |
| 2026-01-28 | PTGX | Protagonist Therapeutics, Inc | M — Option exercise | 12.0K | $12.17 | $146K |
| 2026-01-28 | PTGX | Protagonist Therapeutics, Inc | M — Option exercise | 16.0K | $19.19 | $307K |
| 2026-01-21 | PTGX | Protagonist Therapeutics, Inc | S — Open-market sale | 8.6K | $82.48 | $708K |
Asif Ali serves as Chief Financial Officer of Protagonist Therapeutics, Inc. (PTGX). The SEC filing with CIK 0001921163 dated 2026-01-21 lists him as CFO and shows no reported purchases or sales in that filing, indicating his role as the company's finance leader during the period covered by the filing. Protagonist is a clinical-stage biopharmaceutical company developing constra…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($7.32M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Ali Asif profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.